|
|
|
|
|
Nabio GH |
|
Galanthamine Hydrobromide |
|
Galanthamine Hydrobromide is adopted as the component of some medicines for the treatment of mild to moderate dementia of the Alzheimer's type in clinic. |
|
inhibiting of cholinesterase, increasing the susceptibility of the organism to acetylcholine. |
Industrial field |
pharmaceutical |
|
|
|
|
|
|
|
There are no existing companies to distribute selected chemical product |
|
|
|
|
|